Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/19/2025

Rhinitis Treatment Guidelines

First-Line Treatments

  • The American Academy of Allergy, Asthma, and Immunology recommends intranasal corticosteroids as the most effective monotherapy for both allergic and nonallergic rhinitis, providing superior relief for nasal congestion, rhinorrhea, sneezing, and itching 1
  • Second-generation antihistamines (cetirizine, fexofenadine, loratadine, desloratadine) are preferred over first-generation antihistamines due to less sedation and performance impairment, as suggested by the Journal of Allergy and Clinical Immunology 2
  • Intranasal antihistamines (such as azelastine) may be considered for first-line treatment for both allergic and nonallergic rhinitis, with efficacy equal to or superior to oral second-generation antihistamines for seasonal allergic rhinitis, according to the Journal of Allergy and Clinical Immunology 2
  • For moderate to severe seasonal allergic rhinitis, a combination of intranasal corticosteroid and intranasal antihistamine provides greater efficacy than either alone, as recommended by the American College of Allergy, Asthma, and Immunology 1, 3

Treatment Based on Rhinitis Type

Allergic Rhinitis

  • For mild intermittent or mild persistent allergic rhinitis, the American Academy of Allergy, Asthma, and Immunology suggests second-generation oral antihistamines or intranasal antihistamines 1
  • For moderate to severe persistent allergic rhinitis, intranasal corticosteroids alone or in combination with intranasal antihistamines are recommended by the American College of Allergy, Asthma, and Immunology 1
  • Oral anti-leukotriene agents (montelukast) alone or in combination with antihistamines have proven useful in treating allergic rhinitis, as reported by the Journal of Allergy and Clinical Immunology 4
  • Allergen immunotherapy should be considered for patients with allergic rhinitis who have demonstrable evidence of specific IgE antibodies to clinically relevant allergens, according to the American Academy of Allergy, Asthma, and Immunology 4, 1

Nonallergic Rhinitis

  • Intranasal corticosteroids and intranasal antihistamines are first-line treatments for nonallergic/vasomotor rhinitis, as recommended by the American College of Allergy, Asthma, and Immunology 3
  • Intranasal anticholinergics (ipratropium bromide) are particularly effective for rhinorrhea but have no effect on other nasal symptoms, according to the Journal of Allergy and Clinical Immunology 4
  • The concomitant use of ipratropium bromide nasal spray and an intranasal corticosteroid is more effective than either drug alone for treating rhinorrhea, as suggested by the American College of Allergy, Asthma, and Immunology 4, 5

Additional Treatment Options

  • Intranasal cromolyn sodium is effective in some patients for prevention and treatment of allergic rhinitis with minimal side effects, but is less effective than corticosteroids, as reported by the Journal of Allergy and Clinical Immunology 4
  • Topical saline is beneficial in treating symptoms of chronic rhinorrhea and rhinosinusitis when used as a sole modality or for adjunctive treatment, according to the American Academy of Allergy, Asthma, and Immunology 4, 1
  • Oral decongestants (pseudoephedrine, phenylephrine) can reduce nasal congestion but should be used with caution in patients with hypertension, cardiac arrhythmia, glaucoma, or hyperthyroidism, as recommended by the American College of Allergy, Asthma, and Immunology 4, 3

Treatment Pitfalls to Avoid

  • Using first-generation antihistamines due to their significant sedation, performance impairment, and anticholinergic effects, as warned by the Journal of Allergy and Clinical Immunology 2
  • Prolonged use of intranasal decongestants leading to rhinitis medicamentosa, as cautioned by the American College of Allergy, Asthma, and Immunology 1, 3
  • Recurrent administration of parenteral corticosteroids, which is contraindicated due to potential long-term side effects, according to the Journal of Allergy and Clinical Immunology 4
  • Inadequate treatment of nonallergic rhinitis with oral antihistamines, which are not effective for this condition, as noted by the American College of Allergy, Asthma, and Immunology 3

Environmental Control Measures

  • Avoidance of allergens and irritants is an important component of rhinitis management, as recommended by the American Academy of Allergy, Asthma, and Immunology 2, 1
  • For dust mite allergies, a combination of humidity control, dust mite covers for bedding, HEPA vacuuming of carpeting, and acaricides is suggested by the Journal of Allergy and Clinical Immunology 2
  • For animal allergies, avoidance is the most effective management, as recommended by the American Academy of Allergy, Asthma, and Immunology 2
  • For irritant-triggered rhinitis, avoidance of tobacco smoke, formaldehyde, and other irritants is advised by the Journal of Allergy and Clinical Immunology 2, 3

When to Consider Referral to Specialist

  • For prolonged manifestations of rhinitis not responding to standard therapy, referral to a specialist is recommended by the American College of Allergy, Asthma, and Immunology 1, 3
  • When complications such as nasal polyps, otitis media, or sinusitis develop, referral to a specialist is suggested by the American Academy of Allergy, Asthma, and Immunology 1, 3
  • When systemic corticosteroids have been required, referral to a specialist is advised by the American College of Allergy, Asthma, and Immunology 1, 3
  • For consideration of allergen immunotherapy in allergic rhinitis, referral to a specialist is recommended by the American Academy of Allergy, Asthma, and Immunology 1

REFERENCES

1

Rhinitis Treatment Guidelines [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

3

Treatment of Non-Allergic Rhinitis [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

5

Traitement de la Rhinite Vasomotrice [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025